Search Tag: REMAP-CAP
2022 22 Mar
Thrombotic events are common in patients hospitalised with COVID-19. Platelet activation has been implicated in the COVID-19 inflammatory response. However, the efficacy of antiplatelet therapy in critically ill patients with COVID-19 is still uncertain. The Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia...Read more